Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.

Kana Kurokawa,Yoichiro Mitsuishi,Naoko Shimada, Naoaki Ito, Misa Ogiwara,Keita Miura,Tetsuhiko Asao,Ryo Ko,Takehito Shukuya,Rina Shibayama,Hiromasa Goto,Kazuhisa Takahashi

Thoracic cancer（2023）

引用 3|浏览15

暂无评分

摘要

The incidence of AI among patients treated with pembrolizumab is more frequent than previously reported. In addition, secondary AI, especially isolated ACTH deficiency, is a major form of AI induced by pembrolizumab.

查看译文

关键词

adrenal insufficiency,immune checkpoint inhibitors,immune-related adverse events,non-small-cell lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要